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We	report	a	case	of	invasive	Neisseria sicca/subflava 
meningitis	 after	 a	 spinal	 injection	 procedure	 during	which	
a	face	mask	was	not	worn	by	the	proceduralist.	The	report	
highlights the importance of awareness of, and adherence 
to,	 guidelines	 for	 protective	 face	mask	 use	 during	 proce-
dures that require sterile conditions.
Neisseria sicca/subflava is a known commensal bac-terium of the upper respiratory tract and has rarely 
been found to cause meningitis, endocarditis, or bactere-
mia (1,2). There is limited literature describing the clinical 
course and optimal management of iatrogenic meningitis 
caused by N. sicca/subflava. Infections of the central ner-
vous system caused by this organism occur rarely; most 
reported cases are in the pediatric population (3,4). In the 
literature describing illness in adults, 4 cases of N. sicca 
meningitis are described, 1 of which was an iatrogenic 
case: a complication of ventriculostomy (5). Of 2 case re-
ports of iatrogenic N. subflava meningitis (6,7) 1 case oc-
curred 48 hours after intrathecal injection in a young im-
munocompetent female patient (7). 
Iatrogenic meningitis is a well-documented complica-
tion of lumbar puncture and carries an estimated mortal-
ity of ~35% extrapolated from a US data review (8). Most 
cases occur after catheter insertion or injection into the in-
trathecal space, but infection related to diagnostic lumbar 
puncture is less common. The most frequently identified 
causative organisms in samples are Streptococcus salivar-
ius, Streptococcus viridans and other α-hemolytic strepto-
cocci, Staphylococcus aureus, and Pseudomonas spp. (9).
Multiple case reports of iatrogenic meningitis associ-
ated with nonuse of face masks prompted a review of the 
evidence by the Healthcare Infection Control Practices Ad-
visory Committee, which advises US Health and Human 
Services. The result was a recommendation for the routine 
use of face masks for clinicians placing a catheter or inject-
ing material into the epidural or spinal space, which was 
included in the guideline, 2007 Safe Injection Practices to 
Prevent Transmission of Infection to Patients (10). After 
subsequent outbreaks, the US Centers for Disease Control 
and Prevention released a clinical reminder in 2011 (11).
The Case
We report the case of an independent 78-year-old man 
with low back pain and mild lower limb weakness in whom 
iatrogenic meningitis and associated bacteremia developed 
after a computed tomography myelogram. The procedure 
was performed on June 21, 2013, on an outpatient basis 
in the radiology department of Geelong Hospital, a teach-
ing tertiary hospital. The patient’s medical history included 
atrial fibrillation that was managed by a permanent pace-
maker, which precluded the use of magnetic resonance 
imaging. Other conditions in his medical history included 
hypertension, gout, rash after penicillin exposure, and 
moderate chronic obstructive pulmonary disease that did 
not require long-term prednisone.
The patient underwent fluoroscopy-guided spinal in-
jection of 10 mL of iohexol 300 mgI/mL contrast medium 
from a single-dose vial prepared by a nurse in accordance 
with Centers for Disease Control and Prevention guidelines 
(10). The procedure was performed at the level of lumbar 
disc space 4–5 by using a 22-gauge spinal needle. Aseptic 
measures included the use of sterile gloves, gown, drapes, 
and adequate skin antisepsis by the proceduralist. How-
ever, in conflict with hospital policy, a face mask was not 
used. The procedure was prolonged because the patient’s 
challenging anatomy required multiple passes. The open-
ing pressure was normal; the patient showed no signs of 
complications immediately post-procedure and was dis-
charged after 4 hours of observation.
The patient came to the emergency department within 
18 hours of the procedure after onset of confusion, severe 
headache, neck pain, nausea, vomiting, and fever. The pa-
tient had a deteriorating conscious state; the examination 
showed no additional remarkable findings. Specifically, 
there was no meningism, photophobia, or focal neurologic 
deficit. The puncture site was not inflamed; no other source 
of infection was identified.
The patient’s condition was investigated by using a 
septic screen, including blood cultures and a diagnostic 
lumbar puncture. Subsequently, treatment with intrave-
nous ceftazidime, vancomycin, and dexamethasone were 
commenced for presumed iatrogenic meningitis. The ini-
tial investigations showed a leukocyte count of 16.1×109/L 
and a C-reactive protein level of 9.8 mg/L that increased to 
185 mg/L within 24 hours of the patient’s return. The diag-
nostic lumbar puncture revealed turbid cerebrospinal fluid 
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consisting of 4,260 × 106/L leukocytes, 99% polymorpho-
nuclear leukocytes, 270 × 106/L erythrocytes, and levels of 
3.0 g/L protein, and 1.7 mmol/L glucose.
Initial microscopic examination of cerebrospinal fluid 
revealed a gram-positive coccus; on review, intracellu-
lar diplococci were identified, suggesting an undercol-
ored specimen that likely represented Neisseria species. 
Ceftazidime was discontinued and intravenous ceftriaxone, 
2 g twice daily, was initiated; vancomycin was stopped on 
confirmation of N. sicca/subflava infection. A single set of 
blood cultures initiated on admission were also positive for 
this bacterial species, but subsequent blood cultures were 
negative. The final isolates of N. sicca/subflava from blood 
culture and cerebrospinal fluid were penicillin resistant but 
ceftriaxone sensitive.
The patient required 24 hours of management in the 
intensive care unit because of profound confusion and se-
vere agitation. He improved substantially during a period 
of 7 days in the hospital and was transitioned from intra-
venous ceftriaxone to a 7-day course of oral ciprofloxacin, 
500 mg twice daily, to be completed after discharge. On 
discharge, the patient had improved to his baseline level of 
cognitive function.
The proceduralist who performed the spinal injection 
denied upper respiratory tract symptoms, but admitted to 
not using a face mask because of unawareness of the hos-
pital lumbar puncture protocol mandating face mask use 
when conducting all lumbar punctures. A nasopharyngeal 
swab specimen confirmed that the proceduralist was a car-
rier of N. sicca/subflava who had an identical antibacterial 
drug resistance pattern to that identified in the case-patient. 
Molecular typing of the organism could not be performed 
because the patient’s isolate had been discarded.
Review by the infection control team identified the 
low level of awareness of and adherence to the hospital 
protocol for wearing face masks as a contributory factor. 
No other cases of iatrogenic meningitis could be traced to 
the proceduralist.
Conclusions
We describe the clinical course of iatrogenic meningitis 
caused by N. sicca/subflava with associated bacteremia af-
ter a spinal injection procedure. The suspected mechanism 
of transmission in this case is contamination of the sterile 
field or equipment by oropharyngeal secretions caused by 
nonuse of a face mask by a carrier of this organism. The 
prolonged and technically difficult nature of the procedure 
likely contributed to contamination by increasing exposure. 
This hypothesis is supported by the isolation of N. sicca/
subflava with an identical antimicrobial resistance pattern 
in a swab sample from the proceduralist’s nasopharynx. An 
alternative mechanism could involve oropharyngeal secre-
tions from assistant staff or contamination of the contrast 
medium for spinal injection, although the latter is less like-
ly because it was prepared in accordance with guidelines.
In this case, nonadherence to face mask use standards 
resulted from lack of awareness by the clinician. To im-
prove clinician awareness after this event, the infection 
control unit of the hospital updated its lumbar puncture 
protocol. The protocol mandated the use of face masks for 
all lumbar punctures, and it was disseminated to all clinical 
areas where lumbar punctures were performed.
We believe that the best method for promotion of face 
mask use is making face masks available in preparatory 
areas and procedure rooms and requiring that all lumbar 
punctures are performed with the use of a face mask. We 
also believe there is a need for a system that maintains vigi-
lance. This could include documentation of face mask use 
for all lumbar punctures and intermittent auditing.
In conclusion, N. sicca/subflava, an organism that is 
harmless in the human oropharynx, can cause invasive in-
fection in immunocompetent adults when introduced di-
rectly into the subarachnoid space. Prevention is essential; 
thus, wearing of face masks should be mandatory for all 
personnel present during lumbar punctures and all other 
sterile procedures, and compliance should be monitored.
 Dr Entesari-Tatafi is an advanced trainee in adult acute care 
medicine (general medicine) and a dual trainee in intensive care 
medicine at Barwon Health, Geelong, Australia. His primary re-
search interests are clinical audit and improvement.
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